Regent Pacific Group Limited (HKG:0575)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Biopharma	363.00K	719.00K	291.00K	114.00K	3.25M
Biopharma Growth	-49.51%	147.08%	155.26%	-96.50%	168.48%
Total	363.00K	719.00K	291.00K	114.00K	3.25M
Total Growth	-49.51%	147.08%	155.26%	-96.50%	168.48%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Europe	267.00K	165.00K	243.00K	61.00K	54.00K
Europe Growth	61.82%	-32.10%	298.36%	12.96%	-51.79%
United States	9.00K	18.00K	35.00K	29.00K	-
United States Growth	-50.00%	-48.57%	20.69%	-	-
Asia Pacific	87.00K	536.00K	13.00K	24.00K	-
Asia Pacific Growth	-83.77%	4023.08%	-45.83%	-	-
China	-	-	-	-	3.20M
China Growth	-	-	-	-	300.00%
Total	363.00K	719.00K	291.00K	114.00K	3.25M
Total Growth	-49.51%	147.08%	155.26%	-96.50%	168.48%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 13, 2026

Data Sources Report a data error